Puma Biotechnology (PBYI) Return on Equity [ROE] (2012 - 2026)
Puma Biotechnology's Return on Equity [ROE] came in at 23.35% for Q2 2026, down 18.26 percentage points from 41.61% a year earlier but up 0.87 percentage points from the prior quarter.
Puma Biotechnology (PBYI) Return on Equity [ROE] (2012 - 2026) Analysis & Trends
For FY2025, Puma Biotechnology's Return on Equity [ROE] was 32.17%, down 0.94 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +1074.47 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 33.11% in FY2024 (-24.43 pp), 57.54% in FY2023 (+57.52 pp) and 0.02% in FY2022.
- The five-year range for quarterly Return on Equity [ROE] is -2083.72% (Q1 2022) to 46.94% (Q3 2022).
- Year-over-year, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of -0.19 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2023 (a gain of 2103.97 percentage points), and the weakest in Q1 2022 (a drop of 1572.76 percentage points).
- Business Quant data shows PBYI's Return on Equity [ROE] at 22.48% (Q1 2026), 29.14% (Q4 2025) and 28.10% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Puma Biotechnology | 507.45 Mn | 120.09 Mn | 44.03 Mn | 23.35% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.35% |
| Mar 31, 2026 | 22.48% |
| Dec 31, 2025 | 29.14% |
| Sep 30, 2025 | 28.10% |
| Jun 30, 2025 | 41.61% |
| Mar 31, 2025 | 33.07% |
| Dec 31, 2024 | 28.44% |
| Sep 30, 2024 | 38.87% |
| Jun 30, 2024 | 17.53% |
| Mar 31, 2024 | 29.45% |
| Dec 31, 2023 | 46.84% |
| Sep 30, 2023 | 10.75% |
| Jun 30, 2023 | -8.67% |
| Mar 31, 2023 | 20.25% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 46.94% |
| Jun 30, 2022 | -256.52% |
| Mar 31, 2022 | -2,083.72% |
| Sep 30, 2021 | -520.24% |
| Jun 30, 2021 | -152.97% |
Puma Biotechnology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PBYI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();